Department of Oncology, People's Hospital of Baise, Baise City, Guangxi Province, China.
Department of Oncology, The Affiliated Southwest Hospital of Youjiang Medical University for Nationalities, Baise City, Guangxi Province, China.
J Immunol Res. 2021 Mar 15;2021:5598627. doi: 10.1155/2021/5598627. eCollection 2021.
Neutrophil is known to critically impact the development of renal diseases (e.g., the clear cell renal cell carcinoma (ccRCC)), whereas the heterogeneity of neutrophils in ccRCC remains unclear. In the present study, kidney biopsies from healthy donors and ccRCC tissues were collected for single-cell RNA sequencing (scRNA-seq). In addition, the subpopulations of neutrophils in a healthy kidney and in the tumor microenvironment (TME) of ccRCC were expressed and then analyzed. The genes reported previously were mapped to all subpopulations identified here. On that basis, biological theme comparison and Gene Set Enrichment Analysis (GSEA) were employed to reveal and compare relevant biological functions. In a healthy kidney, neutrophils exhibit two subpopulations: one is more associated with renal autoimmunity, probably acting as therapeutic target; the other is suggested to resist infectious microorganisms. It is noteworthy that six subpopulations were identified in ccRCC biopsy, and two were more relevant to autoimmunity, while the other four are more relevant to the tumor pathology. Besides, ccRCC neutrophil could resist anticancer immune therapies of ipilimumab and pembrolizumab for their low/no expressions of CTLA-4, PD-1, and PD-L1. Thus, this study can help understand the heterogeneity and pathological significance of neutrophils in renal diseases.
中性粒细胞被认为对肾脏疾病(如透明细胞肾细胞癌(ccRCC))的发展具有重要影响,然而,ccRCC 中中性粒细胞的异质性尚不清楚。本研究收集了健康供体的肾活检组织和 ccRCC 组织进行单细胞 RNA 测序(scRNA-seq)。此外,还对健康肾脏和 ccRCC 肿瘤微环境(TME)中的中性粒细胞亚群进行了表达和分析。先前报道的基因被映射到这里鉴定的所有亚群。在此基础上,进行了生物学主题比较和基因集富集分析(GSEA),以揭示和比较相关的生物学功能。在健康的肾脏中,中性粒细胞表现出两个亚群:一个与肾脏自身免疫更相关,可能作为治疗靶点;另一个被认为可以抵抗感染性微生物。值得注意的是,在 ccRCC 活检中鉴定出六个亚群,其中两个与自身免疫更相关,而另外四个与肿瘤病理学更相关。此外,ccRCC 中性粒细胞可以抵抗 ipilimumab 和 pembrolizumab 的抗癌免疫疗法,因为它们低/不表达 CTLA-4、PD-1 和 PD-L1。因此,本研究可以帮助理解肾脏疾病中中性粒细胞的异质性和病理意义。